| PERIOD ENDING | 23-Sep-09 | 24-Jun-09 | 25-Mar-09 | 24-Dec-08 | | Total Revenue | 778,081 | 829,370 | 857,378 | 949,425 | | Cost of Revenue | 219,477 | 677,193 | 707,184 | 818,697 | | | Gross Profit | 558,604 | 152,177 | 150,194 | 130,728 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 493,793 | (70,889) | 143,386 | 40,330 | | Non Recurring |
-
| 134,787 | (88,860) | 83,907 | | Others | 38,869 | 40,139 | 39,858 | 40,647 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 25,942 | 48,140 | 55,810 | (34,156) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,342 | 7,417 | 852 | 193 | | Earnings Before Interest And Taxes | 28,284 | 55,557 | 56,662 | (33,963) | | Interest Expense | 6,948 | 5,886 | 7,452 | 10,535 | | Income Before Tax | 21,336 | 49,671 | 49,210 | (44,498) | | Income Tax Expense | 5,569 | 7,525 | 14,207 | (22,734) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 15,767 | 42,146 | 35,003 | (21,764) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 15,767 | 42,146 | 35,003 | (21,764) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $15,767 | $42,146 | $35,003 | ($21,764) |
|
0.04% Nasdaq 
0.282 (1.96%) 
Income Statement
